Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants

Michael Wilkerson, T. H. Connor, J. K. Wilkin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

2,4-Dinitrochlorobenzene (DNCB) is used for immunotherapy of alopecia areata and verruca vulgaris. We initially postulated that the presence of mutagenic contaminants in commercially available DNCB might account for part of its mutagenicity. We have now characterized changes in the dose-mutagenic response curve of 99% DNCB modified by adding 1% concentrations of known contaminants: 1-chloro-2-nitrobenzene; 1,3-dinitrobenzene; and 2,4-dichloronitrobenzene. Dose-response curves were generated using Salmonella typhimurium tester strains TA-98 and TA-100 at concentrations of 0, 1, 5, 10, 25, 50, and 100 μg per plate in a modified Ames assay. We observed a linear dose-response relationship with a slight, but nonsignificant, shift to the right when contaminants were added. We conclude that DNCB is itself mutagenic, and that contaminants play a minor role in its observed mutagenicity.

Original languageEnglish (US)
Pages (from-to)396-398
Number of pages3
JournalArchives of Dermatology
Volume124
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Dinitrochlorobenzene
2-chloronitrobenzene
Alopecia Areata
Warts
Salmonella typhimurium
Immunotherapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants. / Wilkerson, Michael; Connor, T. H.; Wilkin, J. K.

In: Archives of Dermatology, Vol. 124, No. 3, 1988, p. 396-398.

Research output: Contribution to journalArticle

@article{81acd055c4a948b9a87a4771f6052c0b,
title = "Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants",
abstract = "2,4-Dinitrochlorobenzene (DNCB) is used for immunotherapy of alopecia areata and verruca vulgaris. We initially postulated that the presence of mutagenic contaminants in commercially available DNCB might account for part of its mutagenicity. We have now characterized changes in the dose-mutagenic response curve of 99{\%} DNCB modified by adding 1{\%} concentrations of known contaminants: 1-chloro-2-nitrobenzene; 1,3-dinitrobenzene; and 2,4-dichloronitrobenzene. Dose-response curves were generated using Salmonella typhimurium tester strains TA-98 and TA-100 at concentrations of 0, 1, 5, 10, 25, 50, and 100 μg per plate in a modified Ames assay. We observed a linear dose-response relationship with a slight, but nonsignificant, shift to the right when contaminants were added. We conclude that DNCB is itself mutagenic, and that contaminants play a minor role in its observed mutagenicity.",
author = "Michael Wilkerson and Connor, {T. H.} and Wilkin, {J. K.}",
year = "1988",
language = "English (US)",
volume = "124",
pages = "396--398",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants

AU - Wilkerson, Michael

AU - Connor, T. H.

AU - Wilkin, J. K.

PY - 1988

Y1 - 1988

N2 - 2,4-Dinitrochlorobenzene (DNCB) is used for immunotherapy of alopecia areata and verruca vulgaris. We initially postulated that the presence of mutagenic contaminants in commercially available DNCB might account for part of its mutagenicity. We have now characterized changes in the dose-mutagenic response curve of 99% DNCB modified by adding 1% concentrations of known contaminants: 1-chloro-2-nitrobenzene; 1,3-dinitrobenzene; and 2,4-dichloronitrobenzene. Dose-response curves were generated using Salmonella typhimurium tester strains TA-98 and TA-100 at concentrations of 0, 1, 5, 10, 25, 50, and 100 μg per plate in a modified Ames assay. We observed a linear dose-response relationship with a slight, but nonsignificant, shift to the right when contaminants were added. We conclude that DNCB is itself mutagenic, and that contaminants play a minor role in its observed mutagenicity.

AB - 2,4-Dinitrochlorobenzene (DNCB) is used for immunotherapy of alopecia areata and verruca vulgaris. We initially postulated that the presence of mutagenic contaminants in commercially available DNCB might account for part of its mutagenicity. We have now characterized changes in the dose-mutagenic response curve of 99% DNCB modified by adding 1% concentrations of known contaminants: 1-chloro-2-nitrobenzene; 1,3-dinitrobenzene; and 2,4-dichloronitrobenzene. Dose-response curves were generated using Salmonella typhimurium tester strains TA-98 and TA-100 at concentrations of 0, 1, 5, 10, 25, 50, and 100 μg per plate in a modified Ames assay. We observed a linear dose-response relationship with a slight, but nonsignificant, shift to the right when contaminants were added. We conclude that DNCB is itself mutagenic, and that contaminants play a minor role in its observed mutagenicity.

UR - http://www.scopus.com/inward/record.url?scp=0023931427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023931427&partnerID=8YFLogxK

M3 - Article

C2 - 3278692

AN - SCOPUS:0023931427

VL - 124

SP - 396

EP - 398

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 3

ER -